VRTX Vertex Pharmaceuticals Incorporated

NASDAQ
$520.66

Vertex Pharmaceuticals Incorporated (VRTX) Earnings News

Earnings press releases, previews and reviews for Vertex Pharmaceuticals Incorporated (VRTX), newest first. Our most recent is review: Vertex Misses on EPS as Crinetics and Launch Spending Outpace a Revenue Beat, With CF Growth Cooling Ahead of Povetacicept Decision.